Point72 Middle East FZE’s Repligen RGEN Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2023
Q3
Sell
-5,095
Closed -$721K 1803
2023
Q2
$721K Sell
5,095
-5,771
-53% -$925K 0.02% 670
2023
Q1
$1.83M Buy
+10,866
New +$1.94M 0.06% 350

Other funds holding RGEN

Point72 Middle East FZE's RGEN Position: Q3 2023 in Review

Point72 Middle East FZE sold out of Repligen (RGEN) in Q3 2023, closing a stake of 5,095 shares — an estimated $721K sold.

Point72 Middle East FZE first reported a position in RGEN in Q1 2023 and held it in 2 quarters. The position peaked at $1.83M in Q1 2023. 439 funds tracked by Wall St. Rank hold RGEN as of Q3 2023.

  • Point72 Middle East FZE reported no remaining Repligen position as of Q3 2023 after selling out during the quarter.
  • Point72 Middle East FZE sold 5,095 Repligen shares in Q3 2023, an estimated $721K.
  • Point72 Middle East FZE first reported a position in Repligen in Q1 2023 and held it in 2 quarters.
  • Point72 Middle East FZE's Repligen position peaked at $1.83M in Q1 2023.
  • 439 funds tracked by Wall St. Rank held Repligen as of Q3 2023.

Based on Point72 Middle East FZE's 13F filing for Q3 2023, filed 14 Nov 2023.